Intellectual Property

Patents:

GarCitrin® has been widely patented

7063861 (United States Of America) : Bioavailable Composition of Natural and Synthetic HCA

AU773081 (Australia) : Bioavailable composition of Natural and Synthetic HCA

NZ518116 (New Zealand) : Bioavailable composition of Natural and Synthetic HCA

EP1254209 (Europe) : Bioavailable Composition Of Natural And Synthetic HCA

JP4205943 (Japan) : Bioavailable compositions of Natural and Synthetic HCA